THE PREDICTIVE VALUE OF THE RESULTS OF LABORATORY DIAGNOSTIC TOOL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY DIABETES
https://doi.org/10.38109/2225-1685-2013-2-27-33
Abstract
About the Authors
R. D. KurbanovRussian Federation
A. G. Nikishin
Russian Federation
M. M. Pirnazarov
Russian Federation
M. S. Khasanov
Russian Federation
T. A. Nurbaev
Russian Federation
N. T. Yakubbekov
Russian Federation
S. Ya. Abdullaeva
Russian Federation
References
1. Abid A., Mallick N., Shahbaz A., Tarin S. In-hospital outcome of acute myocardial infarction (st segment elevation type) in diabetics and non-diabetics//J Coll Physicians Surg Pak. - 2005.- Vol.15(9).- P.524-527.
2. ACCF/AHA Cardiovascular Disease & Diabetes Jan. 2013
3. Morgan K. P., Kapur A., Beatt K. J. Anatomy of coronar disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart 2004; 90:732-8.
4. Goldin A., Beckman J., Schmidt A., Creager M. Advanced glycation end products: Sparking the development of diabetic vascular injury// Circulation.-2006. - Vol.114.- P.597- 605.
5. Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 2006; 368:998-1004.
6. Damman P, Hirsch A, Windhausen F, Tijssen JG, de Winter RJ. 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment!n Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. Jam Coll Cardiol 2010;55:858-864.
7. Yan A T ,Yan R T ,Tan M, Eagle K A, Granger C B, Dabbous O H, Fitchett D, Grima E, Langer A, Goodman S G. Inhospital revascularization and one year outcome of acute coronary syndrome patients stratified by the GRACE riskscore. Am J Cardiol 2005;96:913-916.
8. Raikou M., McGuire A., Colhoun H. M., Betteridge D. J., Durrington P. N., Hitman G. A., Neil H. A. W., Livingstone S. J., Charlton-Menys V., Fuller J. H Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS) Diabetologia 2007; 50:733-740
Review
For citations:
Kurbanov R.D., Nikishin A.G., Pirnazarov M.M., Khasanov M.S., Nurbaev T.A., Yakubbekov N.T., Abdullaeva S.Ya. THE PREDICTIVE VALUE OF THE RESULTS OF LABORATORY DIAGNOSTIC TOOL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY DIABETES. Eurasian heart journal. 2013;(2):27-33. (In Russ.) https://doi.org/10.38109/2225-1685-2013-2-27-33